Organization | Universidade Federal do Rio Grande do Norte

Universidade Federal do Rio Grande do Norte Report issue

Academic/Hospital Phase 2

Founded: Natal Brazil (1958)

Organization Overview

First Clinical Trial

2008

NCT01547377

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

JULIANY DE SOUZA ARAUJO | Universidade Federal do Rio Grande do Norte

Active Ingredients

Drugs in Phase 2 Trials (3)

ayahuasca (1 trial)

chlorhexidine (hibitane) (2 trials)

dimethyltryptamine (3 trials)

Drugs in Other Trials (8)

99mtc-dtpa (1 trial)

albuterol (proventil) (1 trial)

fenoterol (1 trial)

ipratropium (atrovent) (2 trials)

l-epigallocatechin (1 trial)

rosuvastatin (crestor) (1 trial)

selenium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Treatment-Resistant (Phase 2)

Gingivitis (Phase 2)

Mucositis (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 10
# of Trial APIs: 11